Îı¾ÃèÊö
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) ? Soft Tissue Sarcoma Version 4.2019 ¡ª September 12, 2019 NCCN NCCN Guidelines for Patients www.nccn/patients ? Continue Version 4.2019, 09/12/19 ? 2019 National Comprehensive Cancer Network (NCCN ), All rights reserved. NCCN Guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. ? Printed by Maria Chen on 9/15/2019 11:36:34 PM. For personal use only. Not approved for distribution. Copyright ? 2019 National Comprehensive Cancer Network, Inc., All Rights Reserved. NCCN Guidelines Version 4.2019 Soft Tissue Sarcoma NCCN Guidelines Index Table of Contents Discussion *Margaret von Mehren, MD/Chair ? Fox Chase Cancer Center David Liebner, MD T ? Richard F. Riedel, MD ? Duke Cancer Institute The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute *John M. Kane, III, MD/Vice-Chair ? Roswell Park Comprehensive Cancer Center Scott Schuetze, MD, PhD ? University of Michigan Rogel Cancer Center Martin McCarter, MD ? University of Colorado Cancer Center Robert S. Benjamin, MD ? The University of Texas MD Anderson Cancer Center Jacob Shabason,MD ¡ì Abramson Cancer Center at the University of Pennsylvania Sean V. McGarry, MD ? ¦Ó Fred & Pamela Bu?ett Cancer Center Marilyn M. Bui, MD, PhD ¡Ù Mo?tt Cancer Center Christian Meyer, MD, PhD ? The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Dale Shepard, MD, PhD ? Case Comprehensive Cancer Center/ University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute Edwin Choy, MD, PhD ? Massachusetts General Hospital Cancer Center Alberto S. Pappo, MD € St. Jude Children¡¯s Research Hospital/ University of Tennessee Health Science Center Jason K. Sicklick, MD ? UC San Diego Moores Canc